April 21 (Reuters) - Valeant Pharmaceuticals International Inc is seeking to name Perrigo Co Plc’s Joseph Papa as its new chief executive, CNBC tweeted, citing Dow Jones.
Valeant is finalizing a contract with the Perrigo CEO and an announcement of his appointment could come as soon as next week, a CNBC tweet said. (bit.ly/1Sf4Jdl)
Valeant and Perrigo could not be reached immediately for comment outside regular business hours. (Reporting by Rama Venkat Raman in Bengaluru; Editing by Gopakumar Warrier)